Braeburn Pharmaceuticals Inc., of Princeton, N.J., reported that the Centers for Medicare & Medicaid Services has granted a Healthcare Common Procedure Coding System code, or permanent J-code, for Probuphine, its six-month buprenorphine implant for the maintenance treatment of opioid addiction.